Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapa...
Leadership
Wesley H. KaupinenFounder
Founder, President, CEO & Director
Matthew E. Korenberg
CFO, Corporate Secretary & Treasurer
Kathleen Goin
Chief Operating Officer
Jeffrey Martini Ph.D.
Chief Scientific Officer
Bohan Wei
Vice President of Corporate Development & New Product Planning
